Wajahat Zafar Mehal MD
Hepatology & Liver Transplantation
Professor, Internal Medicine, Yale University School of Medicine
Join to View Full Profile
40 Temple Street Suite 1aNew Haven, CT 06510
Dr. Mehal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified gastroenterologist and a transplant hepatologist.
My ABIM number is: 180744
Education & Training
- Yale-New Haven Medical CenterFellowship, Gastroenterology, 1995 - 2001
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1993 - 1997
- University of OxfordD.Ph., Immunogenetics, 1993
- Oxford University Medical SchoolClass of 1989
- University of OxfordBA., Physiological Sciences, 1986
Certifications & Licensure
- CT State Medical License 1995 - 2026
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Basic Science Award Miles and Shirley Fiterman Foundation, 2002
- REGAL Award for Research in Gastroenterology 2002
- Award for Basic Science Glaxo Institute for Digestive Health, 2001
- Join now to see all
Clinical Trials
- Irritable Bowel Syndrome and Food Sensitivity Start of enrollment: 2014 Jul 01
- Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome Start of enrollment: 2016 Jan 01
- Inhibition of Sterile Inflammation by Digoxin Start of enrollment: 2021 Mar 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsAcute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone.Kavish R Patidar, Wanzhu Tu, Thomas G Cotter, Douglas A Simonetto, Amon Asgharpour
Hepatology. 2025-04-01 - 4 citationsTherapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH).Albert Do, Frhaan Zahrawi, Wajahat Z Mehal
Nature Reviews. Drug Discovery. 2025-03-01 - Corrigendum to: "A disease-promoting role of the intestinal mycobiome in non-alcoholic fatty liver disease" [J Hepatol (2022) 765-767].Wajahat Z Mehal, Robert F Schwabe
Journal of Hepatology. 2025-02-01
Press Mentions
- Why Is It so Hard to Treat MASH?April 3rd, 2025
- Yale Professors to Tackle Liver Disease in ConnecticutFebruary 6th, 2025
- Bariatric Surgery Enhances Long-Term Outcomes for MASH PatientsJanuary 27th, 2025
- Join now to see all
Grant Support
- Regulation of Liver Fibrosis by Pyruvate Kinase M2 (PKM2)VA CONNECTICUT HEALTHCARE SYSTEM2016–2029
- Sterile Hepatic InflammationVeterans Affairs2011
- Regulation Of Hepatic Repair Responses By Metabolites Of The Uric Acid PathwayNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Kupffer Cell Mediated Deletion Of Activated CD8+ T CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Hepatic Tolerization Of The CD8+ T Cell Immune ResponseNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: